Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Actinium PharmaceuticalsAerpio PharmaceuticalsBiotronZelda TherapeuticsBurcon NutraScience
SymbolNYSEAMERICAN:ATNMNYSE:ARPOASX:BITASX:ZLDTSE:BU
Price Information
Current Price$0.2675$0.80A$0.09A$0.08C$1.12
52 Week RangeBuyBuyN/AN/ABuy
Analyst Ratings
Consensus RecommendationBuyBuyN/AN/ABuy
Consensus Price Target$4.25N/AN/AN/AN/A
% Upside from Price Target1,488.79% upsideN/AN/AN/AN/A
Trade Information
Market Cap$38.68 million$33.08 million$52.42 million$60.43 millionC$95.22 million
BetaN/AN/AN/AN/AN/A
Average Volume1,136,442341,787N/AN/A468,028
Sales & Book Value
Annual RevenueN/AN/A$1.07 million$235,428.00C$40,177.00
Price / SalesN/AN/A48.82256.672,457.77
CashflowN/AN/AA$0.01 per shareA$0.01 per shareC$0.01 per share
Price / CashN/AN/A6.6211.17161.67
Book ValueN/AN/AA$0.01 per shareA$0.01 per shareC($0.05) per share
Price / BookN/AN/A6.7713.33-24.89
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AN/AA$0.00A$0.00C($0.11)
Trailing P/E Ratio0.000.00N/AN/AN/A
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/A650.26%
Current RatioN/AN/A18.75%7.83%0.21%
Quick RatioN/AN/A18.55%7.80%0.14%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees30N/A3N/AN/A
Shares Outstanding162.03 million40.59 million595.68 million755.34 million88.17 million
Next Earnings Date8/8/2019 (Estimated)8/13/2019 (Estimated)N/AN/A8/9/2019 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable
 Actinium PharmaceuticalsAerpio PharmaceuticalsBiotronZelda TherapeuticsBurcon NutraScience

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel